As pharmaceutical companies face increasing pressure to optimize R&D investments and extend the lifecycle of existing assets, drug repositioning has emerged as a strategic pathway to unlock new therapeutic opportunities. This webinar explores how repositioning—whether through new indications, formulations, or delivery routes—can drive innovation, accelerate development timelines, and expand market reach.

Through practical insights and real-world examples, our expert speakers will examine the scientific, regulatory, and commercial dimensions of drug repositioning. Attendees will gain a deeper understanding of how to identify viable candidates, navigate approval pathways, and select appropriate delivery systems to support repositioned therapies.

Whether you’re working in portfolio strategy, clinical development, regulatory affairs, or commercial planning, this session will provide actionable guidance to help you evaluate and execute repositioning initiatives effectively.

This webinar is ideal for professionals in medium to large pharmaceutical companies who are involved in decision-making, development, or commercialization of therapeutic products and want to explore how repositioning can transform existing molecules into new opportunities for patients and markets.